A mold is disclosed for making rotationally asymmetric contact lenses. The mold comprises a first concave or convex surface that is rotationally asymmetric for forming the surface of the contact lens thereagainst, a second concave or convex surface opposed to the first surface that is also rotationally asymmetric, and a segment of the mold between the first and second surfaces having a substantially uniform thickness.
|
1. A contact lens mold comprising:
a first concave or convex surface that is rotationally asymmetric for forming a rotationally asymmetric surface of the contact lens thereagainst, a second convex or concave surface opposed to said first surface that is rotationally asymmetric, a segment of said mold between said first and second surfaces having a substantially uniform thickness.
6. A contact lens mold assembly comprising first and second contact lens mold sections, at least one of said first and second contact lens mold sections comprising:
a first concave or convex surface that is rotationally asymmetric for forming a rotationally asymmetric surface of the contact lens thereagainst, a second convex or concave surface opposed to said first surface that is rotationally asymmetric, a segment of said mold between said first and second surfaces having a substantially uniform thickness.
2. The contact lens mold of
3. The contact lens mold of
4. The contact lens mold of
5. The contact lens mold of
7. The contact lens mold of
a first concave or convex surface that is rotationally asymmetric for forming a rotationally asymmetric surface of the contact lens thereagainst, a second convex or concave surface opposed to said first surface that is rotationally asymmetric, a segment of said mold between said first and second surfaces having a substantially uniform thickness.
8. The contact lens mold assembly of
9. The contact lens mold assembly of
10. The contact lens mold assembly of
11. The contact lens mold of
12. The contact lens mold of
13. The contact lens mold of
14. The contact lens mold of
|
This application is a divisional of Ser. No. 09/095,703, filed on Jun. 9, 1998, now U.S. Pat. No. 5,968,422, which claims the benefit of U.S. Provisional Application No. 60/058,096 filed on Jun. 30, 1997.
This invention relates to a method of injection molding contact lens molds for cast molding contact lenses having a rotationally asymmetric lens surface, and apparatus for carrying out the method.
One method in practice for making contact lenses is cast molding. Cast molding of contact lenses involves depositing a curable mixture of polymerizable monomers in a mold cavity formed by two mold sections, curing the monomer mixture, and disassembling the mold assembly and removing the lens. Other processing steps, for example, hydration in the case of hydrogel lenses, may also be employed. One mold section forms the anterior lens surface (anterior mold section), and the other mold section forms the posterior lens surface (posterior mold section). Prior to the cast molding of the contact lens, each of the mold sections is formed by injection molding a resin in the cavity of an injection molding apparatus. Mounted in the injection molding apparatus are tools for forming the optical surfaces on the mold sections. Whereas the mold sections are typically used only once for casting a lens, the injection molding tools are used to make hundreds of molds.
Several known cast molding methods have the potential to mold a finished contact lens, for example, U.S. Pat. No. 5,271,875 (Appleton et al.). Since these methods avoid time-consuming and labor-intensive operations such as lathing, the methods have been found to offer the potential to reduce production time and cost for the manufacture of spherical contact lenses.
However, various problems have been encountered in employing cast molding technology for manufacturing other types of contact lenses, especially contact lenses that have at least one rotationally asymmetric surface. As one example, toric contact lenses (i.e., contact lenses having a toric optical zone that are used to correct refractive abnormalities of the eye associated pith astigmatism) have at least one surface that is not rotationally symmetric. The problems encountered may be due to several factors. First, the toric optical zone is not spherical. Second, toric contact lenses include some type of ballast (such as prism ballast or slab-off zones) to inhibit rotation of the lens on the eye so that the cylindrical axis of the toric zone remains generally aligned with the axis of the astigmatism; in order to provide such ballast, the edge thickness of the lens is not uniform about the entire circumference of the lens. As another example of such lenses, many mulitfocal designs are not rotationally symmetric.
Applicant found that, in forming contact lens molds for molding lenses having a rotationally asymmetric lens surface, problems were encountered in consistently obtaining contact lens molds having the same geometries. Such inconsistencies in the contact lens mold geometries translated to inconsistencies in cast molding contact lenses in the molds. The present invention solves this problem.
The invention provides an improved method for injection molding a contact lens mold having a rotationally asymmetric molding surface. The method comprises: providing a first molding tool including a convex molding surface, and a second molding tool including a concave molding surface, wherein one of said convex or concave molding surfaces has an optical quality finish and is rotationally asymmetric, said one molding surface for forming an optical surface on the contact lens mold, and the other of said convex or concave molding surface is rotationally asymmetric; positioning the molding tools in opposed relationship to form a space therebetween, such that the respective molding surfaces are spaced substantially uniformly across their surfaces; and injecting a plastic resin into a space formed between the molding surfaces.
The method is especially useful for injection molding contact lens molds having a mold cavity defining surface for forming a toric contact lens surface molded thereagainst, and more particularly, for contact lens molds having a mold cavity defining surface shaped to provide ballast to a contact lens surface molded thereagainst.
The invention further includes an assembly for carrying out the method, and contact lens molds formed by the method.
FIG. 1 is a schematic cross-sectional view of a representative toric contact lens.
FIG. 2 is a schematic exploded view of a representative mold assembly.
FIG. 3 is a schematic cross-sectional view of the mold assembly of FIG. 2 assembled for cast molding a contact lens.
FIG. 4 is a schematic cross-sectional view of tooling for injection molding an anterior mold section of the assembly shown in FIGS. 2 and 3.
FIG. 1 schematically illustrates a representative contact lens having a rotationally asymmetric surface. For this described preferred embodiment, contact lens 1 is a toric contact lens, although the invention is applicable to other contact lenses having at least one rotationally asymmetric surface. As used herein, the term "rotationally asymmetric surface" denotes a surface that is not a second-order surface of revolution, such as a torus section.
Central zone 11 of posterior surface 3 is toric, i.e., this zone has a toric surface that provides the desired cylindrical correction. Posterior surface 3 may optionally include at least one peripheral curve 12 surrounding the central toric zone 11. For the described embodiment, central zone 21 of anterior surface 4 is spherical, and the spherical curve is matched with central zone 11 to provide the desired spherical correction to the lens. Anterior surface 4 includes at least one peripheral curve 22 surrounding central zone 21. Lens 1 is provided with ballast so that the lens maintains a desired rotational orientation on the eye. For the described embodiment, schematically shown in FIG. 1, peripheral section 24 has a different thickness than an opposed peripheral section 25 of the lens periphery due primarily to the ballast in surface 4; thus, anterior surface 4 is not rotationally symmetric. Other ballast types for inhibiting rotation of the contact lens on the eye are known in the art, and the invention is applicable for such other ballast types that require a rotationally asymmetric surface. It is further noted that for toric lens designs, the centerpoint of central zone 21 is not necessarily aligned with the center of lens 1, thereby further contributing to surface 4 not being rotationally symmetric.
A representative mold assembly 25 for the method of this invention is shown in FIGS. 2 and 3. The mold assembly includes posterior mold 30 having a posterior mold cavity defining surface 31 (which forms the posterior surface of the molded lens), and anterior mold 40 having an anterior mold cavity defining surface 41 (which forms the anterior surface of the molded lens). Each of the mold sections is injection molded from a plastic resin, such as polypropylene or polystyrene, in an injection molding apparatus, as described in more detail below. When the mold sections are assembled, a mold cavity 32 is formed between the two defining surfaces that corresponds to the desired shape of the contact lens molded therein. Accordingly, for the described embodiment, posterior mold cavity defining surface 31 has a toric central zone (for forming the toric posterior surface of the toric contact lens) having a cylindrical axis, and anterior mold cavity defining surface 41 has a configuration that will provide ballast to a lens molded in mold cavity 32. Of course, surfaces 31, 41 may also include curves for forming desired peripheral curves on the lens, and the central zones of surfaces 31, 41 may be designed to provide a desired spherical correction to the molded toric lens.
As mentioned above, the posterior and anterior mold sections are injection molded from a plastic resin in an injection molding apparatus. FIG. 4 illustrates schematically an injection mold arrangement for the injection molding of anterior mold section 40. As seen in the Figures, anterior mold section 40 includes surface 42 opposed to anterior mold cavity defining surface 41, surfaces 41 and 42 defining segment 43 therebetween of mold section 40. Tools 51,52 are mounted in the injection molding apparatus. Tool 51 has an optical quality finish on its molding surface 53 since tool 51 is used to form mold anterior cavity defining surface 41. (As used herein, the term "optical quality finish" denotes a molding surface that is sufficiently smooth for ultimately forming the optical surface of a contact lens, e.g., the produced contact lens is suitable for placement in the eye without the need to machine or polish the formed lens surface.) Tool 52, used to form opposed surface 42, does not need to have an optical quality finish on its molding surface 54 since opposed surface 42 of contact lens mold 40 does not contact the polymerizable lens mixture in casting contact lenses, i.e., opposed surface 42 does not form part of mold cavity 32.
According to conventional methods of injection molding such a contact lens mold, the shape of opposed surface 42 was not considered particularly critical. Therefore, tool molding surface 54 would generally have a shape that was easy to machine in order to avoid unnecessary labor and expense in forming the molding surface on tool 52, i.e., this tool molding surface would be formed of rotationally symmetric curves especially spherical curves.
However, applicant found that, in forming contact lens molds for molding lenses having a rotationally asymmetric lens surface, a problem of inconsistent molding of contact lens molds was encountered. More specifically, it was discovered that when surface 53 of tool 52 was made with a rotationally symmetric molding surface as in conventional methods, it was difficult to obtain contact lens molds having consistent geometries, which translated to inconsistencies in the casting of lenses in the contact lens molds. It is believed that there was still sufficient mismatch between the shapes of surfaces 41 and 42, especially in the region of the molding surfaces that provide ballast, that uneven resin flow occurred in injection molding the contact lens mold, thus causing the inconsistency in the injection molding process.
The present invention solved this problem by providing molding tool 52 with a molding surface 54 that is rotationally asymmetric, such that when the two molding tools 51,52 are positioned in opposed relationship, molding surfaces 53,54 are spaced substantially uniformly across their surfaces. Preferably, tools 51 and 52 are locked into these positions with respect to one another. It is believed that this uniformity in the space formed between the molding surfaces 53,54 results in more uniform flow of resin during injection molding, and thereby provides more consistency in the injection molding of the contact lens mold sections. Preferably, surface 54 has curves approximating each of the curves on surface 53. Molding surfaces 53, 54 should be shaped so that the thickness of section 43 varies no more than 0.2 mm, more preferably no more than 0.15 mm, and especially no more than 0.1 mm, across its profile.
(It is noted that due to the scale of FIG. 4, the various curves of surfaces 41 and 42 are not visibly illustrated; similarly, the various curves of surface 31 is not illustrated in FIG. 3. However, for the described embodiment, it is evident that surface 31 would be shaped to provide contact lens surface 21, and surfaces 41,42 of the tools would be shaped accordingly. As discussed above, for the described embodiment, lens 1 does not include a uniform peripheral thickness due primarily to inclusion of a ballast.)
Tools 51,52 are typically made from brass, stainless steel or nickel or some combination thereof, and the desired molding surface is formed on the tools according to generally methods known in the art, such as lathe cutting. Alternately, if the tool surface has a shape that is difficult to lathe cut, other methods are generally available in the art, such as electrodischarge machining. After forming the desired surface, surface 53 of tool 51 is polished to achieve precision surface quality so that no surface imperfections are transferred to the mold section being injection molded therefrom. Surface 54 of tool 52 does not require such degree of polishing, since it is not used to form an optical surface, and therefore, the molding surface 54 of tool 52 does not need to correspond exactly to surface 53. As shown schematically in FIG. 4, the end of tool 52 opposite surface 54 is designed to mount the tool in insert 55, surrounded by ejector sleeve 56, and tool 51 is surrounded by sleeve 57. This assembly is mounted in blocks 58,59, with a gate 60 provided for introducing resin As would be apparent to one skilled in the art, the exact design or configuration to accommodate the molding tools will depend on the injection molding apparatus.
Although certain preferred embodiments have been described, it is understood that the invention is not limited thereto and modifications and variations would be evident to a person of ordinary skill in the art. As one example, the invention is applicable to toric contact lenses having other ballast means than that illustrated for the described embodiment, and for other types of contact lenses having at least one rotationally asymmetric surface. As another example, the invention is not limited to injection molding of anterior mold sections, but is also applicable to injection molding of posterior mold sections that have a rotationally asymmetric mold cavity defining surface. As yet another example, the invention is applicable to contact lens mold types other than those illustrated in FIGS. 2 to 4, and the various injection molding set-ups therefor.
Patent | Priority | Assignee | Title |
10130759, | Mar 09 2012 | Picolife Technologies, LLC | Multi-ported drug delivery device having multi-reservoir cartridge system |
10213549, | Dec 01 2011 | Picolife Technologies, LLC | Drug delivery device and methods therefor |
10245420, | Jun 26 2012 | PicoLife Technologies | Medicament distribution systems and related methods of use |
6476971, | Oct 31 2000 | Eastman Kodak Company | Method of manufacturing a microlens array mold and a microlens array |
6595639, | Nov 10 2000 | COOPERVISION INTERNATIONAL LIMITED | Junctionless ophthalmic lenses and methods for making same |
6939486, | Jun 25 2002 | Bausch & Lomb Incorporated | Apparatus and method for making intraocular lenses |
7152975, | Nov 10 2000 | COOPERVISION INTERNATIONAL LIMITED | Junctionless ophthalmic lenses and methods for making same |
7156641, | Jan 03 2000 | Johnson & Johnson Vision Care, Inc. | Mold for forming a contact lens and method of preventing formation of small strands of contact lens material during contact lens manufacture |
7585167, | Dec 30 2004 | Bausch & Lomb Incorporated | Core locking assembly and method for orientation of asymmetric tooling |
7828431, | Nov 10 2000 | COOPERVISION INTERNATIONAL LIMITED | Junctionless ophthalmic lenses and methods for making same |
7935280, | Dec 30 2004 | Core locking assembly and method for orientation of asymmetric tooling | |
8638964, | Oct 10 2008 | Widex A/S | Method for manufacturing a hearing aid having a custom fitted resilient component |
8663538, | Feb 12 2009 | Picolife Technologies, LLC | Method of making a membrane for use with a flow control system for a micropump |
8764425, | Feb 12 2009 | Picolife Technologies, LLC | Mold for making a membrane for use with a flow control system for a micropump |
8771229, | Dec 01 2011 | Picolife Technologies, LLC | Cartridge system for delivery of medicament |
8790307, | Dec 01 2011 | Picolife Technologies, LLC | Drug delivery device and methods therefor |
8807169, | Feb 12 2009 | Picolife Technologies, LLC | Flow control system for a micropump |
9883834, | Apr 16 2012 | PicoLife Technologies | Medication delivery device with multi-reservoir cartridge system and related methods of use |
9993592, | Dec 01 2011 | Picolife Technologies, LLC | Cartridge system for delivery of medicament |
Patent | Priority | Assignee | Title |
5110278, | Nov 30 1990 | Novartis AG | Injection molding apparatus for producing a toric lens casting mold arbor |
5271875, | Sep 12 1991 | Bausch & Lomb Incorporated | Method for molding lenses |
5407062, | Jan 28 1994 | Bausch & Lomb Incorporated | Contact lens mold packaging |
5456864, | Sep 29 1992 | Bausch & Lomb Incorporated | Method of making plastic molds for molding contact lenses |
5466147, | Sep 12 1991 | Bausch & Lomb Incorporated | Apparatus for molding lenses |
5601759, | Oct 05 1993 | Bausch & Lomb Incorporated | Method for molding contact lenses |
5611970, | Jan 31 1994 | Bausch & Lomb Incorporated | Method of cast molding toric contact lenses |
5702735, | Jun 10 1994 | JOHNSON & JOHNSON VISION PRODUCTS INC | Molding arrangement to achieve short mold cycle time |
5716540, | Feb 09 1996 | Johnson & Johnson Vision Products, Inc.; JOHNSON & JOHNSON VISION PRODUCTS, INC | Apparatus and method for producing center gated lens molds for contact lens manufacture |
5843346, | Jun 30 1994 | Bausch & Lomb Incorporated | Method of cast molding contact lenses |
JP405337957, | |||
WO9407684, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Sep 09 1999 | Bausch & Lomb Incorporated | (assignment on the face of the patent) | / | |||
Mar 20 2008 | B&L VPLEX HOLDINGS, INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | B&L SPAF INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | B&L FINANCIAL HOLDINGS CORP | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | B & L DOMESTIC HOLDINGS CORP | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | B&L CRL PARTNERS L P | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | B&L CRL INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | WP PRISM INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | Bausch & Lomb Incorporated | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | B&L MINORITY DUTCH HOLDINGS LLC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | BAUSCH & LOMB INTERNATIONAL INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | BAUSCH & LOMB CHINA, INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | WILMINGTON PARTNERS L P | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | WILMINGTON MANAGEMENT CORP | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | SIGHT SAVERS, INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | RHC HOLDINGS, INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | Iolab Corporation | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | BAUSCH & LOMB TECHNOLOGY CORPORATION | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | BAUSCH & LOMB SOUTH ASIA, INC | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
Mar 20 2008 | BAUSCH & LOMB REALTY CORPORATION | CREDIT SUISSE | SECURITY AGREEMENT | 020733 | /0765 | |
May 18 2012 | Credit Suisse AG, Cayman Islands Branch | Bausch & Lomb Incorporated | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 028726 | /0142 | |
May 18 2012 | Bausch & Lomb Incorporated | CITIBANK N A , AS ADMINISTRATIVE AGENT | SECURITY AGREEMENT | 028728 | /0645 | |
May 18 2012 | EYEONICS, INC | CITIBANK N A , AS ADMINISTRATIVE AGENT | SECURITY AGREEMENT | 028728 | /0645 | |
Aug 05 2013 | CITIBANK N A , AS ADMINISTRATIVE AGENT | WP PRISM INC N K A BAUSCH & LOMB HOLDINGS INC | RELEASE OF SECURITY INTEREST | 030995 | /0444 | |
Aug 05 2013 | CITIBANK N A , AS ADMINISTRATIVE AGENT | Bausch & Lomb Incorporated | RELEASE OF SECURITY INTEREST | 030995 | /0444 | |
Aug 05 2013 | CITIBANK N A , AS ADMINISTRATIVE AGENT | ISTA PHARMACEUTICALS | RELEASE OF SECURITY INTEREST | 030995 | /0444 | |
Aug 30 2013 | Bausch & Lomb Incorporated | GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT | SECURITY AGREEMENT | 031156 | /0508 | |
Jan 08 2015 | GOLDMAN SACHS LENDING PARTNERS, LLC | BARCLAYS BANK PLC, AS SUCCESSOR AGENT | NOTICE OF SUCCESSION OF AGENCY | 034749 | /0689 | |
Jul 17 2017 | Bausch & Lomb Incorporated | The Bank of New York Mellon | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 043251 | /0932 | |
Feb 13 2018 | VALEANT CANADA LP | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | Valeant Pharmaceuticals International | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | VALEANT PHARMACEUTICALS NORTH AMERICA LLC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | WIRRA IP PTY LIMITED | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | VALEANT PHARMA POLAND SP Z O O | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | VALEANT PHARMACEUTICALS LUXEMBOURG S A R L | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | VALEANT PHARMACEUTICALS IRELAND LIMITED | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | ORAPHARMA, INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | Technolas Perfect Vision GmbH | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | SYNERGETICS USA, INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | ATON PHARMA, INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | SOLTA MEDICAL, INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | SYNERGETICS USA, INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | Technolas Perfect Vision GmbH | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | VALEANT CANADA LP | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | Valeant Pharmaceuticals International | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | WIRRA IP PTY LIMITED | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | VALEANT PHARMA POLAND SP Z O O | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | VALEANT PHARMACEUTICALS LUXEMBOURG S A R L | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | VALEANT PHARMACEUTICALS IRELAND LIMITED | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | SANTARUS, INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | Salix Pharmaceuticals, Ltd | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | Bausch & Lomb Incorporated | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | BAUSCH & LOMB PHARMA HOLDINGS CORP | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | COMMONWEALTH LABORATORIES, LLC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | DOW PHARMACEUTICAL SCIENCES, INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | ECR PHARMACEUTICALS CO , INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | LABORATOIRE CHAUVIN S A S | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | Medicis Pharmaceutical Corporation | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | ONPHARMA INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | PRECISION DERMATOLOGY, INC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Feb 13 2018 | ATON PHARMA, INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | Bausch & Lomb Incorporated | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | DOW PHARMACEUTICAL SCIENCES, INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | ECR PHARMACEUTICALS CO , INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | LABORATOIRE CHAUVIN S A S | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | Medicis Pharmaceutical Corporation | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | ONPHARMA INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | ORAPHARMA, INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | PRECISION DERMATOLOGY, INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | Salix Pharmaceuticals, Ltd | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | SANTARUS, INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | COMMONWEALTH LABORATORIES, LLC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | SOLTA MEDICAL, INC | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | BAUSCH & LOMB PHARMA HOLDINGS CORP | THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0634 | |
Feb 13 2018 | VALEANT PHARMACEUTICALS NORTH AMERICA LLC | BARCLAYS BANK PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 045444 | /0299 | |
Oct 18 2022 | The Bank of New York Mellon | LABORATOIRE CHAUVIN S A S | OMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 045444 0634 | 061872 | /0295 | |
Oct 18 2022 | The Bank of New York Mellon | Bausch & Lomb Incorporated | OMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 045444 0634 | 061872 | /0295 | |
Oct 18 2022 | The Bank of New York Mellon | The United States of America, as represented by the Secretary, Department of Health and Human Services | OMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 045444 0634 | 061872 | /0295 | |
Oct 18 2022 | The Bank of New York Mellon | Technolas Perfect Vision GmbH | OMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 045444 0634 | 061872 | /0295 | |
Oct 19 2022 | BARCLAYS BANK PLC | Technolas Perfect Vision GmbH | RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 | 061779 | /0001 | |
Oct 19 2022 | BARCLAYS BANK PLC | Bausch & Lomb Incorporated | RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 | 061779 | /0001 | |
Oct 19 2022 | BARCLAYS BANK PLC | PF Consumer Healthcare 1 LLC | RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 | 061779 | /0001 | |
Oct 19 2022 | BARCLAYS BANK PLC | LABORATOIRE CHAUVIN S A S | RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 | 061779 | /0001 | |
Oct 19 2022 | BARCLAYS BANK PLC | The United States of America, as represented by the Secretary, Department of Health and Human Services | RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 | 061779 | /0001 |
Date | Maintenance Fee Events |
Mar 18 2005 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Mar 25 2009 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Feb 07 2013 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Oct 23 2004 | 4 years fee payment window open |
Apr 23 2005 | 6 months grace period start (w surcharge) |
Oct 23 2005 | patent expiry (for year 4) |
Oct 23 2007 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 23 2008 | 8 years fee payment window open |
Apr 23 2009 | 6 months grace period start (w surcharge) |
Oct 23 2009 | patent expiry (for year 8) |
Oct 23 2011 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 23 2012 | 12 years fee payment window open |
Apr 23 2013 | 6 months grace period start (w surcharge) |
Oct 23 2013 | patent expiry (for year 12) |
Oct 23 2015 | 2 years to revive unintentionally abandoned end. (for year 12) |